Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Maria Victória Souto-Silva"'
Autor:
Maria Victória Souto-Silva, Elizabete C. I. Bispo, Lucas F. F. Albuquerque, Stefhani Barcelos, Emãnuella M. Garcez, Luana S. Quilici, Florêncio Figueiredo Cavalcanti Neto, Eliza Carla Barroso Duarte, Jankerle N. Boeloni, Felipe Saldanha-Araujo, Guilherme M. Gelfuso, Juliana Lott Carvalho
Publikováno v:
Pharmaceutics, Vol 16, Iss 11, p 1377 (2024)
Background/Objectives: Ibrutinib (IBR) is a tyrosine kinase inhibitor under investigation in preclinical and clinical settings as an alternative treatment for melanoma. Nevertheless, the limited oral bioavailability of IBR and the need for high doses
Externí odkaz:
https://doaj.org/article/a757fb23569542d8a8ffb47b08adc185
Autor:
Fernanda Vitelli Lins, Elizabete Cristina Iseke Bispo, Naomí Souza Rodrigues, Maria Victória Souto Silva, Juliana Lott Carvalho, Guilherme Martins Gelfuso, Felipe Saldanha-Araujo
Publikováno v:
Biomedicines, Vol 12, Iss 5, p 1012 (2024)
Ibrutinib, a tyrosine kinase inhibitor with a broad spectrum of action, has been successfully explored to treat hematological and solid cancers. Herein, we investigated the anti-cancer effect of Ibrutinib on melanoma cell lines. Cytotoxicity was eval
Externí odkaz:
https://doaj.org/article/311532a666b0483a8d0c21ce7d91752a
Autor:
Saulo José Figueiredo Mendes, Aline Gonçalves Monteles, Jhady Steffane Silva Duailibe Pereira, Alanna Rubia Ribeiro, Fernanda Karolinne Melo Fernandes, Lucas Girão Ferreira, Itallo Patrick Sousa Amorim, Maria Victória Souto Silva, Fernanda de Oliveira Holanda
Publikováno v:
Farmácia Clínica e Atenção Farmacêutica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b0782041008a19cd2a11eb12a475551
https://doi.org/10.22533/at.ed.91819191110
https://doi.org/10.22533/at.ed.91819191110
